Cargando…

Sulphonamide inhibition studies of the β-carbonic anhydrase from the bacterial pathogen Clostridium perfringens

The β-carbonic anhydrases (CAs, EC 4.2.1.1) from the pathogenic bacterium Clostridium perfringens (CpeCA) was recently characterised kinetically and for its anion inhibition profile. In the search of effective CpeCA inhibitors, possibly useful to inhibit the growth/pathogenicity of this bacterium, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Vullo, Daniela, Kumar, R. Siva Sai, Scozzafava, Andrea, Ferry, James G., Supuran, Claudiu T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009973/
https://www.ncbi.nlm.nih.gov/pubmed/29098923
http://dx.doi.org/10.1080/14756366.2017.1388233
_version_ 1783333503137480704
author Vullo, Daniela
Kumar, R. Siva Sai
Scozzafava, Andrea
Ferry, James G.
Supuran, Claudiu T.
author_facet Vullo, Daniela
Kumar, R. Siva Sai
Scozzafava, Andrea
Ferry, James G.
Supuran, Claudiu T.
author_sort Vullo, Daniela
collection PubMed
description The β-carbonic anhydrases (CAs, EC 4.2.1.1) from the pathogenic bacterium Clostridium perfringens (CpeCA) was recently characterised kinetically and for its anion inhibition profile. In the search of effective CpeCA inhibitors, possibly useful to inhibit the growth/pathogenicity of this bacterium, we report here an inhibition study of this enzyme with a panel of aromatic, heterocyclic and sugar sulphonamides/sulphamates. Some sulphonamides, such as acetazolamide, ethoxzolamide, dichlorophenamide, dorzolamide, sulthiame and 4-(2-hydroxymethyl-4-nitrophenyl-sulphonamido)ethylbenzenesulphonamide were effective CpeCA inhibitors, with K(I)s in the range of 37.4–71.6 nM. Zonisamide and saccharin were the least effective such inhibitors, whereas many other aromatic and heterocyclic sulphonamides were moderate – weak inhibitors with K(I)s ranging between 113 and 8755 nM. Thus, this study provides the basis for developing better clostridial enzyme inhibitors with potential as antiinfectives with a new mechanism of action.
format Online
Article
Text
id pubmed-6009973
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-60099732018-07-11 Sulphonamide inhibition studies of the β-carbonic anhydrase from the bacterial pathogen Clostridium perfringens Vullo, Daniela Kumar, R. Siva Sai Scozzafava, Andrea Ferry, James G. Supuran, Claudiu T. J Enzyme Inhib Med Chem Research Paper The β-carbonic anhydrases (CAs, EC 4.2.1.1) from the pathogenic bacterium Clostridium perfringens (CpeCA) was recently characterised kinetically and for its anion inhibition profile. In the search of effective CpeCA inhibitors, possibly useful to inhibit the growth/pathogenicity of this bacterium, we report here an inhibition study of this enzyme with a panel of aromatic, heterocyclic and sugar sulphonamides/sulphamates. Some sulphonamides, such as acetazolamide, ethoxzolamide, dichlorophenamide, dorzolamide, sulthiame and 4-(2-hydroxymethyl-4-nitrophenyl-sulphonamido)ethylbenzenesulphonamide were effective CpeCA inhibitors, with K(I)s in the range of 37.4–71.6 nM. Zonisamide and saccharin were the least effective such inhibitors, whereas many other aromatic and heterocyclic sulphonamides were moderate – weak inhibitors with K(I)s ranging between 113 and 8755 nM. Thus, this study provides the basis for developing better clostridial enzyme inhibitors with potential as antiinfectives with a new mechanism of action. Taylor & Francis 2017-11-03 /pmc/articles/PMC6009973/ /pubmed/29098923 http://dx.doi.org/10.1080/14756366.2017.1388233 Text en © 2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Paper
Vullo, Daniela
Kumar, R. Siva Sai
Scozzafava, Andrea
Ferry, James G.
Supuran, Claudiu T.
Sulphonamide inhibition studies of the β-carbonic anhydrase from the bacterial pathogen Clostridium perfringens
title Sulphonamide inhibition studies of the β-carbonic anhydrase from the bacterial pathogen Clostridium perfringens
title_full Sulphonamide inhibition studies of the β-carbonic anhydrase from the bacterial pathogen Clostridium perfringens
title_fullStr Sulphonamide inhibition studies of the β-carbonic anhydrase from the bacterial pathogen Clostridium perfringens
title_full_unstemmed Sulphonamide inhibition studies of the β-carbonic anhydrase from the bacterial pathogen Clostridium perfringens
title_short Sulphonamide inhibition studies of the β-carbonic anhydrase from the bacterial pathogen Clostridium perfringens
title_sort sulphonamide inhibition studies of the β-carbonic anhydrase from the bacterial pathogen clostridium perfringens
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009973/
https://www.ncbi.nlm.nih.gov/pubmed/29098923
http://dx.doi.org/10.1080/14756366.2017.1388233
work_keys_str_mv AT vullodaniela sulphonamideinhibitionstudiesofthebcarbonicanhydrasefromthebacterialpathogenclostridiumperfringens
AT kumarrsivasai sulphonamideinhibitionstudiesofthebcarbonicanhydrasefromthebacterialpathogenclostridiumperfringens
AT scozzafavaandrea sulphonamideinhibitionstudiesofthebcarbonicanhydrasefromthebacterialpathogenclostridiumperfringens
AT ferryjamesg sulphonamideinhibitionstudiesofthebcarbonicanhydrasefromthebacterialpathogenclostridiumperfringens
AT supuranclaudiut sulphonamideinhibitionstudiesofthebcarbonicanhydrasefromthebacterialpathogenclostridiumperfringens